BETA
BETA
IMTX
immatics biotechnologies GmbH
IMTXW9
$3.36arrow_drop_down2.04%-$0.07
Penny Stock
IMTX
IMTXW9
$3.36
arrow_drop_down2.04%Performance History
| Key Stats | |
|---|---|
| Open | $3.20 |
| Prev. Close | $3.20 |
| EPS | - |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 3.20 | 3.43 |
| 52 Week Range | 1.79 | 4.14 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | - |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
Price$23.75
Perf. (24h)
arrow_drop_down0.34%-$0.08
Market Cap$36.94B
Price$23.39
Perf. (24h)
arrow_drop_up0.30%$0.07
Market Cap$36.68B
Price$25.02
Perf. (24h)
arrow_drop_up0.08%$0.02
Market Cap$12.73B
About immatics biotechnologies GmbH (IMTXW)
- Sector
- Industry
- CEO
- Headquarters
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on immatics biotechnologies GmbH
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is immatics biotechnologies GmbH's (IMTXW) price per share?
The current price per share for immatics biotechnologies GmbH (IMTXW) is $3.36. The stock has seen a price change of -$0.07 recently, indicating a -2.04% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for immatics biotechnologies GmbH (IMTXW)?
For immatics biotechnologies GmbH (IMTXW), the 52-week high is $4.14, which is 23.21% from the current price. The 52-week low is $1.79, the current price is 87.71% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is immatics biotechnologies GmbH (IMTXW) a growth stock?
immatics biotechnologies GmbH (IMTXW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying immatics biotechnologies GmbH as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is immatics biotechnologies GmbH (IMTXW) stock price performance year to date (YTD)?
As of the latest data, immatics biotechnologies GmbH (IMTXW) has a year-to-date price change of 24.91%. Over the past month, the stock has experienced a price change of 12%. Over the last three months, the change has been 58.49%. Over the past six months, the figure is -8.45%.
help
Is immatics biotechnologies GmbH (IMTXW) a profitable company?
immatics biotechnologies GmbH (IMTXW) has a net income of -$96.99M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -44.5% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$101.72M. Furthermore, the EBITDA is -$91.36M.
help
What is the market capitalization of immatics biotechnologies GmbH (IMTXW)?
immatics biotechnologies GmbH (IMTXW) has a market capitalization of . The average daily trading volume is 992, indicating the stock's liquidity and investor engagement.
News
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.